Benign mimics of prostatic adenocarcinoma

被引:15
|
作者
Trpkov, Kiril [1 ,2 ]
机构
[1] Univ Calgary, Calgary Lab Serv, Dept Pathol & Lab Med, 7007 14 St, Calgary, AB T2V 1P9, Canada
[2] Univ Calgary, Rockyview Gen Hosp, 7007 14 St, Calgary, AB T2V 1P9, Canada
关键词
ATYPICAL ADENOMATOUS HYPERPLASIA; METHYLACYL-COA RACEMASE; BASAL-CELL HYPERPLASIA; ISUP CONSENSUS CONFERENCE; NEEDLE-BIOPSY CORES; NEPHROGENIC ADENOMA; SCLEROSING ADENOSIS; HISTOLOGIC FEATURES; PARTIAL ATROPHY; GRANULOMATOUS PROSTATITIS;
D O I
10.1038/modpathol.2017.136
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Benign mimics present either as common challenges in daily routine practice or may cause diagnostic dilemmas because some are less commonly seen and one may be less familiar in recognizing them. There are a multitude of mimics of prostatic adenocarcinoma, which may represent normal gland structures, benign proliferations, atrophic lesions, hyperplastic or metaplastic changes, and inflammatory processes. Some of them are preferentially found in certain anatomic areas of the prostate, either confined to the prostate, or outside of the gland. Various benign mimics of prostatic carcinoma may be also evaluated based on their morphologic similarity to Gleason patterns 3-5 of prostatic adenocarcinoma. Most of the mimics are easily recognizable in larger specimens, such as TUR of the prostate or radical prostatectomy specimens, but they may pose diagnostic problems when the evaluation is done on limited tissue, such as needle-core biopsies or if prostate specimens are infrequently encountered in practice. Therefore, before signing out a report with a diagnosis of prostatic carcinoma, pathologists should carefully consider and rule out the various benign lesions that may mimic carcinoma. This is particularly relevant in the current prostate biopsy practice which relies on using extended biopsy core templates. The awareness and familiarity with the characteristic features of the mimics and judicial use of additional ancillary tests, including immunohistochemistry can prevent overdiagnosis and false-positive interpretation. This review provides a contemporary update on the broad spectrum of the benign prostatic lesions that can mimic prostate adenocarcinoma, outlines their key morphologic and immunohistochemical diagnostic features, and provides a diagnostic, pattern-based approach in establishing a correct diagnosis and distinguishing them reliably from prostatic adenocarcinoma.
引用
收藏
页码:S22 / S46
页数:25
相关论文
共 50 条
  • [31] PROSTATE-SPECIFIC DELETION OF CDH1 IN MICE MIMICS PROSTATIC PERFUSION OF BENIGN PROSTATIC HYPERPLASIA (BPH) PATIENTS
    Tyagi, Pradeep
    Pascal, Laura
    Foley, Lesley
    Frederick, Robin
    Hitchens, T. Kevin
    Kanai, Anthony
    Yoshimura, Naoki
    Wang, Zhou
    JOURNAL OF UROLOGY, 2021, 206 : E201 - E202
  • [32] Low grade adenocarcinoma simulating benign glandular lesions in needle prostatic biopsy
    AristaNasr, J
    Cortes, E
    Pichardo, R
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1997, 49 (01): : 37 - 40
  • [33] Comparing the Immunoexpression of FUT3 and FUT6 between Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
    de Albuquerque Vasconcelos, Juliana Lucia
    Ferreira, Steffany de Almeida
    Rosendo de Lima, Amanda Lucena
    Barreto de Melo Rego, Moacyr Jesus
    Galdino Bandeira, Ana Rosa
    Bezerra Cavalcanti, Carmelita de Lima
    de Melo Lira, Mariana Montenegro
    Carneiro Beltrao, Eduardo Isidoro
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2013, 46 (03) : 105 - 109
  • [34] Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy
    vanderKwast, TH
    Tetu, B
    Fradet, Y
    Dupont, A
    Gomez, J
    Cusan, L
    Diamond, P
    Labrie, F
    PROSTATE, 1996, 28 (04): : 227 - 231
  • [35] Glutathione S-transferase:: differential expression of α, μ, and π isoenzymes in benign prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma
    Bostwick, David G.
    Meiers, Isabelle
    Shanks, Jonathan H.
    HUMAN PATHOLOGY, 2007, 38 (09) : 1394 - 1401
  • [36] A novel immunohistochemical assay (ProEX™ C) aids in the distinction of cervical adenocarcinoma in situ and adenocarcinoma from benign glandular mimics
    Aximu, D.
    Colgan, T. J.
    Azad, A.
    Ni, R.
    Nanji, S. S.
    MODERN PATHOLOGY, 2008, 21 : 196A - 196A
  • [37] A novel immunohistochemical assay (ProEX™ C) aids in the distinction of cervical adenocarcinoma in situ and adenocarcinoma from benign glandular mimics
    Axinni, D.
    Colgan, T. J.
    Azad, A.
    Ni, R.
    Nanji, S. S.
    LABORATORY INVESTIGATION, 2008, 88 : 196A - 196A
  • [38] ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma
    Johnson, Hunter
    Zhou, Ming
    Osunkoya, Adeboye O.
    HUMAN PATHOLOGY, 2013, 44 (10) : 2241 - 2246
  • [39] ERG Expression in Mucinous Prostatic Adenocarcinoma and Prostatic Adenocarcinoma with Mucinous Features: Comparison with Conventional Prostatic Adenocarcinoma
    Johnson, H.
    Zhou, M.
    Osunkoya, A. O.
    LABORATORY INVESTIGATION, 2012, 92 : 216A - 216A
  • [40] ERG Expression in Mucinous Prostatic Adenocarcinoma and Prostatic Adenocarcinoma with Mucinous Features: Comparison with Conventional Prostatic Adenocarcinoma
    Johnson, H.
    Zhou, M.
    Osunkoya, A. O.
    MODERN PATHOLOGY, 2012, 25 : 216A - 216A